Citation Impact
Citing Papers
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
2010
Pathobiology of liver fibrosis: a translational success story
2015
Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy
2013
Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis
2014
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis
2014
Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
2012
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
2020
Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
2013
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
2016
Necroptosis and its role in inflammation
2015 StandoutNature
Epithelial-mesenchymal transition in tissue repair and fibrosis
2016
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Regulation of Innate and Adaptive Immunity by TGFβ
2017
Mechanisms of hepatic stellate cell activation
2017 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? – A mechanistic hypothesis
2015
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
2011
The role of the gut microbiota in nonalcoholic fatty liver disease
2010
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
2018
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
2009
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
2012
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
2016
Hallmarks of aging: An expanding universe
2023 Standout
Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver
2016
Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin
2017
The role of stem cells in liver repair and fibrosis
2009
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease
2015
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
2016
Origins and functions of liver myofibroblasts
2013
Evidence against a Stem Cell Origin of New Hepatocytes in a Common Mouse Model of Chronic Liver Injury
2014
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
2013
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice
2014
Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury
2012
Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner
2013
Evidence for Mesenchymal−Epithelial Transition Associated with Mouse Hepatic Stem Cell Differentiation
2011
NAFLD and diabetes mellitus
2016
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
2015
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
2014
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
2015
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
2012
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Effects of mild calorie restriction on lipid metabolism and inflammation in liver and adipose tissue
2017
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Genetic Labeling Does Not Detect Epithelial-to-Mesenchymal Transition of Cholangiocytes in Liver Fibrosis in Mice
2010
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
2015
Non-alcoholic fatty liver disease
2021 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Evolving challenges in hepatic fibrosis
2010
New Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
2012
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
2011
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
2015
Chronic cold exposure results in subcutaneous adipose tissue browning and altered global metabolism in Qinghai-Tibetan plateau pika (Ochotona curzoniae)
2018 StandoutNobel
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
2015
Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
2015
HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers
2018
Adipocytokines and hepatic fibrosis
2015
EMT: 2016
2016 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Cellular and molecular mechanisms in liver fibrogenesis
2014
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis
2011
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
2011
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease
2012
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
2015
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
2013
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Prognostic Value of Controlled Attenuation Parameter by Transient Elastography
2017
Potential approaches to reverse or repair renal fibrosis
2014
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
2015
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
2013
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Hedgehog signaling in the liver
2010
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Past, present and future perspectives in nonalcoholic fatty liver disease
2019
Hepatic progenitor cell represents a transitioning cell population between liver epithelium and stroma
2011
Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
2020
NAFLD: A multisystem disease
2015 Standout
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
2010
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease
2017
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice
2013
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hepatocellular carcinoma
2022 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis
2021
Natural killer T cells in liver injury, inflammation and cancer
2015
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome
2012
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
2015
Hepatocellular Carcinoma
2019 Standout
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EpCAM and the biology of hepatic stem/progenitor cells
2014
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
2016
Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
2019
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
The pan‐caspase inhibitor Emricasan (IDN ‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
2019
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
2014
Exosome‐mediated activation of toll‐like receptor 3 in stellate cells stimulates interleukin‐17 production by γδ T cells in liver fibrosis
2016
Steatosis and Steatohepatitis: Complex Disorders
2014
Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia
2010
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
2015
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Loss of MicroRNA‐101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes
2015
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
2016
Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases
2013
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
2019
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
2012
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
2013
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Osteopontin at the Crossroads of Inflammation and Tumor Progression
2017
Hepatostat: Liver regeneration and normal liver tissue maintenance
2016
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Works of Wing‐Kin Syn being referenced
Hedgehog regulates yes‐associated protein 1 in regenerating mouse liver
2016
Activation of Rac1 Promotes Hedgehog-Mediated Acquisition of the Myofibroblastic Phenotype in Rat and Human Hepatic Stellate Cells
2010
Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
2010
Role for hedgehog pathway in regulating growth and function of invariant NKT cells
2009
Osteopontin splice variants and polymorphisms in cancer progression and prognosis
2017
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non‐alcoholic steatohepatitis
2005
Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis
2019
Genetic differences in oxidative stress and inflammatory responses to diet‐induced obesity do not alter liver fibrosis in mice
2009
Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway
2010
Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics
2012
Role of liver progenitors in acute liver injury
2013
Osteopontin mediates an MZF1–TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer
2014
Signals from dying hepatocytes trigger growth of liver progenitors
2010
Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis
2009
Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans
2008
Hedgehog Signaling Is Critical for Normal Liver Regeneration After Partial Hepatectomy in Mice
2010
The role of Hedgehog signaling in fibrogenic liver repair
2010
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Similarities and Differences in the Pathogenesis of Alcoholic and Nonalcoholic Steatohepatitis
2009
Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production†
2009
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #
2009
Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma
2010
Natural History of Unexplained Chronic Hepatitis After Liver Transplantation
2007
Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease
2009
Liver Cell–Derived Microparticles Activate Hedgehog Signaling and Alter Gene Expression in Hepatic Endothelial Cells
2008
Smoothened is a master regulator of adult liver repair
2013
Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis
2009
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
2017
Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
2013
Macrophage‐derived hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni
2012